Can taltz cause fungal infections like thrush?

Does Taltz raise the risk of fungal infections?

Taltz blocks a protein involved in inflammation and immune signaling. By doing so, it weakens defenses against fungi and other microbes. This explains why fungal infections, including thrush, appear in clinical data and real-world use.

How often do fungal infections occur with Taltz use?

Data from clinical trials show rates of fungal infections ranging from 1.4% to 4.1% in psoriasis patients. Higher rates are seen in patients who receive Taltz for psoriatic arthritis or ankylosing spondylitis. Real-world reports submitted to the FDA also list thrush as a frequent complaint.

Why does Taltz allow fungi to overgrow?

Taltz inhibits IL-17A, a cytokine that keeps mucosal surfaces clear of yeast. When this pathway is blocked, Candida species gain a foothold on the skin and mucous membranes. The company acknowledges this known effect in its prescribing information.

What happens if you get thrush while taking Taltz?

Most cases stay mild and respond to antifungal treatment such as nystatin or fluconazole. Patients are advised to report any white patches in the mouth, burning, or swallowing pain. Treatment continues unless the infection proves severe or recurrent.

How long does Taltz-related thrush take to resolve?

Typical cases clear in 7–14 days once antifungal therapy is started. Severe or recurrent episodes may require stopping Taltz temporarily until the infection is brought under control.

When does Taltz patent expire?

Taltz holds patents covering composition of matter, formulation, and methods of use. Those rights extend until at least 2030 in the U.S. and Europe. Early reports suggest biosimilar versions may begin challenging these rights sooner.

Why are companies challenging this patent?

Generic makers cite obviousness and lack of inventive step in claims covering the monoclonal antibody itself.